Biotech · Private company · Charlotte, NC, US
Oncotab, Inc
Track this companyFree. Adds Oncotab, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Combination Therapy of T-Cell Engager and Chemotherapy for Pancreatic Cancer TreatmentFiscal year 2026 · $1.1MNIH RePORTER 1R44CA306447-01A1 · fetched Nov 12, 2026
- Optimized targeted radiotherapy of pancreatic cancerFiscal year 2025 · $400KNIH RePORTER 1R41CA284997-01A1 · fetched Nov 12, 2026